伊拉斯卡制药 ERAS
$14.41 +$1.14 (+8.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.57 +1.11%
开盘$13.42
昨收$13.27
当日区间$13.11 – $14.43
成交量4.03M
市值$5.04B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$47.62M-55.5% YoY
净利润-$44.08M-30.1% YoY
摊薄每股收益-$0.14-16.7% YoY
自由现金流-$27.28M-4.7% YoY
经营现金流-$27.27M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-78.2%
资产收益率-65.2%
投入资本回报率-73.1%
流动比率8.29
负债/资产比率16.8%
现金及投资$268.74M
总负债$39.27M
净现金（净负债）$229.47M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $47.62M | $37.91M | $131.41M | $32.60M | $32.55M |
| 销售及管理费用 | $11.72M | $10.65M | $38.55M | $9.36M | $10.07M |
| -管理费用 | $11.72M | $10.65M | $38.55M | $9.36M | $10.07M |
| 研发费用 | $35.90M | $27.27M | $92.85M | $23.24M | $22.47M |
| 营业利润 | -$47.62M | -$37.91M | -$131.41M | -$32.60M | -$32.55M |
| 非经营性利息净收入（支出） | $3.60M | $4.45M | $16.61M | $3.57M | $3.97M |
| 非经营性利息收入 | $3.60M | $4.45M | $16.61M | $3.57M | $3.97M |
| 其他收入（支出） | -$63,000.00 | -$149.98M | -$9.75M | -$54,000.00 | -$2.04M |
| 特殊收益（费用） | $0.00 | -$150.00M | -$9.50M | $0.00 | -$2.00M |
| 其他非经营性收入（支出） | -$63,000.00 | $22,000.00 | -$248,000.00 | -$54,000.00 | -$37,000.00 |
| 税前利润 | -$44.08M | -$183.44M | -$124.55M | -$29.09M | -$30.61M |
| 净利润 | -$44.08M | -$183.44M | -$124.55M | -$29.09M | -$30.61M |
| 持续经营利润 | -$44.08M | -$183.44M | -$124.55M | -$29.09M | -$30.61M |
| 归属母公司净利润 | -$44.08M | -$183.44M | -$124.55M | -$29.09M | -$30.61M |
| 归属普通股股东净利润 | -$44.08M | -$183.44M | -$124.55M | -$29.09M | -$30.61M |
| 基本每股收益 | -$0.14 | -$0.60 | -$0.44 | -$0.10 | -$0.11 |
| 摊薄每股收益 | -$0.14 | -$0.60 | -$0.44 | -$0.10 | -$0.11 |
| -减：其他特殊支出 | – | $150.00M | $9.50M | $0.00 | $2.00M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $435.05M | $461.23M | $396.15M | $396.15M | $420.40M |
| 流动资产合计 | $278.44M | $253.78M | $286.24M | $286.24M | $299.93M |
| 现金及现金等价物与短期投资 | $268.74M | $243.79M | $276.08M | $276.08M | $288.40M |
| -现金及现金等价物 | $42.54M | $47.26M | $73.81M | $73.81M | $70.23M |
| -短期投资 | $226.20M | $196.53M | $202.27M | $202.27M | $218.17M |
| 其他流动资产 | $9.70M | $10.00M | $10.16M | $10.16M | $11.53M |
| 非流动资产合计 | $156.61M | $207.45M | $109.92M | $109.92M | $120.48M |
| 固定资产净值 | $39.39M | $40.88M | $42.33M | $42.33M | $44.12M |
| -固定资产原值 | $53.42M | $54.19M | $54.99M | $54.99M | $56.04M |
| -累计折旧 | -$14.03M | -$13.31M | -$12.66M | -$12.66M | -$11.92M |
| 投资及预付款 | $115.53M | $164.72M | $65.72M | $65.72M | $73.98M |
| -可供出售证券 | $115.53M | $164.72M | $65.72M | $65.72M | $73.98M |
| 其他非流动资产 | $1.69M | $1.85M | $1.86M | $1.86M | $2.38M |
| 负债合计 | $73.19M | $67.71M | $70.98M | $70.98M | $72.52M |
| 流动负债合计 | $33.57M | $26.66M | $28.51M | $28.51M | $28.71M |
| 应付款 | $2.02M | $2.16M | $981,000.00 | $981,000.00 | $3.03M |
| -应付账款 | $2.02M | $2.16M | $981,000.00 | $981,000.00 | $3.03M |
| 一年内应计费用 | $18.00M | $12.70M | $10.39M | $10.39M | $11.86M |
| 短期债务及融资租赁负债 | $5.44M | $5.25M | $5.07M | $5.07M | $4.89M |
| -一年内到期融资租赁负债 | $5.44M | $5.25M | $5.07M | $5.07M | $4.89M |
| 非流动负债合计 | $39.61M | $41.04M | $42.47M | $42.47M | $43.80M |
| 长期债务及融资租赁负债 | $39.27M | $40.70M | $42.07M | $42.07M | $43.41M |
| -长期融资租赁负债 | $39.27M | $40.70M | $42.07M | $42.07M | $43.41M |
| 其他非流动负债 | $341,000.00 | $340,000.00 | $399,000.00 | $399,000.00 | $395,000.00 |
| 股东权益合计 | $361.87M | $393.53M | $325.17M | $325.17M | $347.89M |
| 股东权益 | $361.87M | $393.53M | $325.17M | $325.17M | $347.89M |
| 股本 | $31,000.00 | $31,000.00 | $28,000.00 | $28,000.00 | $28,000.00 |
| -普通股 | $31,000.00 | $31,000.00 | $28,000.00 | $28,000.00 | $28,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.48B | $1.47B | $1.22B | $1.22B | $1.21B |
| 留存收益 | -$1.12B | -$1.08B | -$892.21M | -$892.21M | -$863.12M |
| 不影响留存收益的损益 | -$1.25M | -$699,000.00 | $628,000.00 | $628,000.00 | $649,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$27.27M | -$27.38M | -$95.46M | -$21.71M | -$21.66M |
| 持续经营经营活动现金流净额 | -$27.27M | -$27.38M | -$95.46M | -$21.71M | -$21.66M |
| 持续经营净利润 | -$44.08M | -$183.44M | -$124.55M | -$29.09M | -$30.61M |
| 持续经营损益 | $0.00 | -$47,000.00 | – | – | – |
| 折旧、折耗与摊销 | $716,000.00 | $723,000.00 | $3.11M | $743,000.00 | $755,000.00 |
| 其他非现金项目 | $0.00 | $150.00M | $9.50M | $0.00 | $2.00M |
| 营运资金变动 | $7.02M | -$2.33M | -$3.33M | $1.40M | $1.26M |
| -预付资产变动 | $1.00M | $175,000.00 | $1.79M | $2.18M | -$903,000.00 |
| -应付账款及应计费用变动 | $6.47M | -$2.09M | -$3.26M | -$378,000.00 | $2.56M |
| -其他营运资金变动 | -$450,000.00 | -$421,000.00 | -$1.86M | -$403,000.00 | -$397,000.00 |
| 投资活动现金流净额 | $19.49M | -$243.83M | $100.43M | $24.71M | $25.70M |
| 持续经营投资活动现金流净额 | $19.49M | -$243.83M | $100.43M | $24.71M | $25.70M |
| 固定资产购置及出售净额 | -$8,000.00 | -$36,000.00 | -$128,000.00 | -$9,000.00 | -$6,000.00 |
| 无形资产购置及出售净额 | $0.00 | -$150.00M | -$9.50M | $0.00 | -$4.00M |
| 投资购置及出售净额 | $19.50M | -$93.79M | $110.05M | $24.72M | $29.71M |
| 筹资活动现金流 | $3.06M | $244.66M | $1.10M | $575,000.00 | $41,000.00 |
| 持续经营筹资活动现金流净额 | $3.06M | $244.66M | $1.10M | $575,000.00 | $41,000.00 |
| 普通股发行净额 | $0.00 | $258.75M | $0.00 | $0.00 | $0.00 |
| 股票期权行使所得 | $3.36M | $1.96M | $1.10M | $575,000.00 | $41,000.00 |
| 其他筹资费用净额 | -$300,000.00 | -$16.04M | – | – | – |
| 期末现金余额 | $42.95M | $47.66M | $74.21M | $74.21M | $70.64M |
| 现金净变动 | -$4.71M | -$26.55M | $6.07M | $3.58M | $4.09M |
| 期初现金余额 | $47.66M | $74.21M | $68.15M | $70.64M | $66.55M |
| 自由现金流 | -$27.28M | -$177.42M | -$105.08M | -$21.72M | -$25.66M |
暂无评论——快来第一个聊聊 ERAS。
登录后参与讨论。